Axovant (AXGT) Prices 14.03M Share Common Offering at $3.75/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
After-Hours Stock Movers 02/19: (STMP) (ZG) (CAR) Higher (TVTY) (OSUR) (AXGT) Lower (more...)
February 19, 2020 5:43 PM ESTToday's After-Hours Stock Movers
Tivity Health, Inc. (NASDAQ: TVTY) 32.4% LOWER; reported Q4 EPS of $0.40, $0.15 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $272.8 million versus the consensus estimate of $275.15 million. Tivity Health, Inc. sees Q1 2020 revenue of $335-350 million, versus the consensus of $363.4 million. Tivity Health, Inc. sees FY2020 revenue of $1.243-1.285 billion, versus the consensus of $1.34 billion. Tivity Health Announces Departure of CEO Donato J. Tramuto and Appoints Healthcare Veteran as Interim CEO
Axovant (AXGT) to Offer Common Stock
February 19, 2020 4:03 PM ESTAxovant Gene Therapies Ltd. (Nasdaq: AXGT) announced that it has commenced an underwritten public offering of its common shares and pre-funded warrants to purchase its common shares. In connection with this offering, Axovant expects to grant the underwriters a 30-day option to purchase... More
